OCP Approves Learning Framework for Three Pharmacy Services Still Awaiting Authorization

Ontario pharmacists have a new planning signal, not a new permission to practise. At its September 28–29, 2026 meeting, the Ontario College of Pharmacists (OCP) approved learning guidance and annual-declaration changes connected with three anticipated services: acute pharyngitis, otitis externa and buprenorphine administration. The board's report says government approval for those activities is still outstanding.

Key takeaways

The distinction is between preparing practitioners and legally authorizing services. OCP plans to bring an implementation proposal to its December board meeting and describes the guidance as temporary, with a review after two years. The report is the source for the decision; earlier consultation documents should not be mistaken for the final implementation instructions.

What the board actually approved

OCP’s September report says the board revised both its guidance for specified expanded-scope activities and proposed annual declaration statements for Part A pharmacists after reviewing consultation feedback. The three activities named in the report are acute pharyngitis, otitis externa and administration of buprenorphine. The declaration mechanism is intended to let registrants attest to competence as the profession’s scope evolves; it is not itself a clinical authorization or a substitute for government approval. The guidance is described as temporary and scheduled for review after two years. Read OCP’s board report.

There are therefore two separate decisions to watch. The government must authorize the activities; only then would the revised learning and declaration changes take effect. OCP has also said it will bring a reasonable implementation plan to its December 2026 board meeting. That future plan may answer practical questions that the September decision does not settle, including how practitioners demonstrate learning, how pharmacies prepare workflows and when services may be offered. Until final instructions are published, a pharmacy should avoid representing an anticipated service as already available.

Preparing without promising a launch

A sensible response is to identify learning and operational gaps now, while keeping patient-facing service descriptions aligned with current authorization. Buying equipment, taking a course or changing a declaration does not by itself establish legal authority to offer a service.

Pharmasist's view is that readiness requires more than a training certificate: pharmacies should consider consultation time, assessment space, referral arrangements and follow-up capacity before deciding whether a new service fits their setting.

Practice guidance for pharmacists

• Use OCP's final implementation communications, rather than an old consultation draft, to check what is required.
• List the knowledge and practical skills your team would need for any service it intends to offer.
• Keep internal preparation separate from public advertising of services not yet authorized.
• Review staffing, private assessment space and referral pathways alongside education plans.
• Confirm government authorization and the applicable start date before changing practice.

The next meaningful updates will be the government's scope decision and OCP's implementation directions. This is an Ontario development and should not be generalized to other provinces.